Hospitalization, Asthma Phenotypes, and Readmission Rates in Pre-school Asthma
Authors:
Open Access
- 20 November 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 8
Abstract
Objective: Children with pre-school asthma suffer disproportionally more often from severe asthma exacerbations with emergency visits and hospital admissions compared to school children. Despite this high disease burden, there are only a few reports looking at this particular severe asthma cohort. Similarly, there is little real-life research on the distribution of asthma phenotypes and personalized treatment at discharge in this age group.Patients and Methods: Retrospective analysis of the electronic charts of all children aged 1–5 years with asthma hospitalizations (ICD J45) at the Frankfurt University between 2008 and 2017. An acute severe asthma exacerbation was defined as dyspnea, oxygen demand, and/or systemic steroid therapy. Age, gender, duration of hospitalization, asthma phenotype, treatment, and readmission rate were analyzed.Results: Of 572 patients, 205 met the definition of acute severe asthma. The phenotypic characterization showed 56.1% had allergic asthma, 15.2% eosinophilic asthma and 28.7% non-allergic asthma. Of these patients, 71.7% were discharged with inhaled corticosteroids (ICS) or ICS + long-acting-beta-agonists (LABA), 15.1% with leukotriene antagonists (LTRA) and 7.3% salbutamol on demand. The rate of emergency presentations (emergency department and readmission) within 12 months after discharge was high (n = 42; 20.5%). No phenotype tailored treatment was detectable. Neither the number of eosinophils (>300/μl) nor the treatment at discharge had an effect on emergency visits and readmission rate.Conclusion: Despite protective therapy with ICS, ICS + LABA, or LTRA, the readmission rate was high. Thus, current care and treatment strategies should be reevaluated continuously, in order to better control asthma in pre-school children and prevent hospitalization.Keywords
Funding Information
- Boehringer Ingelheim
This publication has 35 references indexed in Scilit:
- Viral infections and the development of asthma in childrenTherapeutic Advances in Infectious Disease, 2013
- Epidemiology of virus-induced wheezing/asthma in childrenFrontiers in Microbiology, 2013
- Step-up Therapy for Children with Uncontrolled Asthma Receiving Inhaled CorticosteroidsNew England Journal of Medicine, 2010
- Predicting short term response to anti-inflammatory therapy in young children with asthmaCurrent Medical Research and Opinion, 2009
- Status of Childhood Asthma in the United States, 1980–2007Pediatrics, 2009
- Early Detection of Airway Wall Remodeling and Eosinophilic Inflammation in Preschool WheezersAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled studyThe Lancet, 2006
- Montelukast Reduces Asthma Exacerbations in 2- to 5-Year-Old Children with Intermittent AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Hospital admissions and readmissions for asthma in the age group 0-4 yearsPediatric Pulmonology, 2001
- Risk factors for readmission to hospital for asthma in childhood.Thorax, 1994